Valneva’s Lyme disease vaccine offers beacon of hope amid 2025 sales dip
Following a difficult year that saw Ixchiq’s license suspended in the US, Valneva is pinning hopes on upcoming pipeline candidates.
20 February 2026
20 February 2026
Following a difficult year that saw Ixchiq’s license suspended in the US, Valneva is pinning hopes on upcoming pipeline candidates.
Analysis by WHO estimates that 6.2 million lives could be saved if next-generation vaccines are used through to 2050.
Boehringer Ingelheim will provide NIPER Raebareli access to the opnMe portal, facilitating scientific advancement in healthcare.
The collaboration will combine Syngene’s preclinical development expertise with VivaMed's AI-generated therapeutic hypotheses.
The Pennsylvania site is one of four US-based manufacturing sites J&J plans to build over the next four years.
Under the agreement, UNP will receive up to $100m in upfront and pre-IND milestone payments.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.